Whistleblowers incentives, disincentives, and protection strategies
"The book will discuss business protection strategies and best practices in dealing with whistleblowers, as well as the GlaxoSmithKline, Pfizer and other high profile whistleblower cases. The book is expected to appeal to Board members, C-Suite executives, corporate compliance personnel, attorn...
| Main Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Hoboken, N.J.
Wiley
2012
|
| Subjects: | |
| Online Access: | |
| Collection: | O'Reilly - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references and index
- Front Matter
- Introduction
- The Whistleblowers and the Dodd₆Frank Incentives. The Dramatic Expansion of Whistleblower Awards under Dodd₆Frank
- The Remarkable Story of Cheryl Eckard and the $96 Million Bounty under the False Claims Act
- The Pfizer Whistleblowers who Collected Over $100 Million under the False Claims Act
- Disincentives and Factors Motivating Public Disclosure. Disincentives to Internal Whistleblowers
- Women as Whistleblowers: Factors Motivating Public Whistleblowing
- Organizational Best Practices. Why Should Organizations Adopt a Robust Whistleblower System?
- Establishing a Robust Whistleblower System
- Statutory Incentives and Sec Award Regulations. The False Claims Act: Qui Tam Cases
- IRS Whistleblowers
- Other Statutory Incentives and Protections for Whistleblowers
- A Step₆by₆Step Guide to SEC Whistleblowers Awards under Dodd₆Frank
- Appendix 1: IRS Form 211
- Appendix 2: SEC Form TCR
- Tip, Complaint or Referral
- Appendix 3: SEC Form WB-APP
- Application for Award for Original Information Submitted Pursuant to Section 21F of the Securities Exchange Act of 1934
- Appendix 4: SEC Whistleblower Rules
- About the Author
- Index